FIELD: medicine, pharmacy. SUBSTANCE: solution for inhalation contains the following components, wt.-%: glutoxime that represents bis-(gamma-L-glutamyl)-L-cysteinyl-bis-glycine disodium salt, 1.90-2.10; theophylline, 0.45-0.55; riboxin, 0.90-1.10; dimexide, 2.80-3.20; sodium chloride, 0.75-0.95; water for injection, the balance, up to 10 g. Glutoxime-base solution provides dispersion of microparticles in the range 5-10 mcm in inhalation through nebulizer with compress feeding compressed air (oxygen). Agent shows cytoprotective, immunomodulating, broncholytic, desensitizing, antibacterial and anti-inflammatory activity. Invention proposes also method for prophylaxis and treatment of chronic diseases of lower respiratory ways of viral and bacterial genesis by administration of indicated solution to patient. EFFECT: valuable medicinal properties of solution. 9 cl, 3 tbl, 5 ex
Title | Year | Author | Number |
---|---|---|---|
AEROSOL FOR INHALATIONS OF GLUTOVENT PHARMACEUTICAL COMPOSITION AND METHOD FOR ITS USING IN THERAPY | 2001 |
|
RU2190422C1 |
METHOD OF IMMUNE INSUFFICIENCY CORRECTION IN PATIENTS WITH MECHANICAL JAUNDICE OF NON-TUMOUR GENESIS | 2009 |
|
RU2414892C2 |
METHOD FOR TREATING DIFFERENT FORMS OF PULMONARY TUBERCULOSIS, RESISTANT TO ANTITUBERCULAR CHEMOTHERAPY, AMONG THEM | 2001 |
|
RU2197984C1 |
AEROSOL FOR INHALATIONS IN OBSTRUCTIVE BRONCHITIS | 2020 |
|
RU2735502C1 |
METHOD FOR PREVENTION AND TREATMENT OF CICATRICAL STENOSES OF LARYNX AND TRACHEA | 2009 |
|
RU2388477C1 |
PHARMACEUTICAL COMPOSITIONS CONTAINING CYCLOSPORINE | 2006 |
|
RU2421209C2 |
INDIRECT METHOD FOR TREATING THE PATIENTS SUFFERING FROM BRONCHIAL ASTHMA | 1996 |
|
RU2099071C1 |
FILLER FOR CAPSULAR INHALER | 2016 |
|
RU2634258C1 |
METHOD FOR TREATING THE CASES OF PSORIASIS | 2002 |
|
RU2218172C1 |
COMBINATION AND PHARMACEUTICAL PREPARATION FOR TREATING INFLAMMATORY AND OBSTRUCTIVE RESPIRATORY DISEASES | 2005 |
|
RU2438660C2 |
Authors
Dates
2003-11-27—Published
2002-03-18—Filed